Ridgemont Equity Partners, a middle market private equity investor headquartered in Charlotte, North Carolina, has acquired HemaSource Intermediate Holdings LLC, distributor of medical products to the plasma collection industry based in West Jordan. Financial terms of the transaction were not disclosed.
HemaSource distributes consumable products across 1,300 SKUs from two strategically located distribution centers. The company utilizes a proprietary cloud-based inventory management and business intelligence software solution to help its customers gain supply chain efficiencies and decrease their plasma collection costs.
“HemaSource is an ideal investment for Ridgemont as we are active investors in both value-added distribution and pharma services,” said Scott Poole, partner at Ridgemont. “The company is well-positioned given the strong demand drivers for plasma-derived therapeutics, which fuels the need for consumables during the plasma donation process. We’re excited to partner with the HemaSource management team and continue to grow the company together.”
“We believe that Ridgemont is the best partner for the HemaSource team as we enter the next chapter of our business,” said Tom Jordan, CEO of HemaSource. “Ridgemont distinguished themselves with their knowledge of our business and the plasma end-markets. There are many exciting initiatives to pursue ahead of us and we look forward to working with Ridgemont to accomplish our goals.”
